| Year |
Citation |
Score |
| 2012 |
Shechter Y, Sasson K, Marcus Y, Rubinraut S, Lev-Goldman V, Fridkin M. Establishing the principle of reversibility in peptide/protein and small-molecule therapy. Therapeutic Delivery. 3: 17-23. PMID 22833930 DOI: 10.4155/Tde.11.133 |
0.466 |
|
| 2012 |
Shechter Y, Sasson K, Lev-Goldman V, Rubinraut S, Rubinstein M, Fridkin M. Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin. Bioconjugate Chemistry. 23: 1577-86. PMID 22759320 DOI: 10.1021/Bc3000854 |
0.522 |
|
| 2011 |
Fridkin G, Maina T, Nock BA, Blat D, Lev-Goldman V, Scolnik Y, Kapitkovski A, Vachutinsky Y, Shechter Y, Levy Y. Intramolecular azo-bridge as a cystine disulfide bond surrogate: Somatostatin-14 and brain natriuretic peptide (BNP) analogs. Bioorganic & Medicinal Chemistry. 19: 798-806. PMID 21194956 DOI: 10.1016/J.Bmc.2010.12.014 |
0.419 |
|
| 2010 |
Sasson K, Marcus Y, Lev-Goldman V, Rubinraut S, Fridkin M, Shechter Y. Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 214-20. PMID 19883707 DOI: 10.1016/J.Jconrel.2009.10.028 |
0.5 |
|
| 2008 |
Lev-Goldman V, Mester B, Ben-Aroya N, Hanoch T, Rupp B, Stanoeva T, Gescheidt G, Seger R, Koch Y, Weiner L, Fridkin M. Conjugates of gonadotropin releasing hormone (GnRH) with carminic acid: Synthesis, generation of reactive oxygen species (ROS) and biological evaluation. Bioorganic & Medicinal Chemistry. 16: 6789-98. PMID 18571926 DOI: 10.1016/J.Bmc.2008.05.057 |
0.454 |
|
| 2006 |
Lev-Goldman V, Mester B, Ben-Aroya N, Koch Y, Weiner L, Fridkin M. Synthesis and active oxygen generation by new emodin derivatives and their gonadotropin-releasing hormone conjugates. Bioconjugate Chemistry. 17: 1008-16. PMID 16848409 DOI: 10.1021/Bc050293R |
0.483 |
|
| Show low-probability matches. |